Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
High Tide initiated with a Neutral at Cantor Fitzgerald » 16:50
11/22/21
11/22
16:50
11/22/21
16:50
HITI

High Tide

$6.68 /

+0.56 (+9.15%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Pablo Zuanic initiated coverage of High Tide with a Neutral rating and C$8.75 price target.

ShowHide Related Items >><<
HITI High Tide
$6.68 /

+0.56 (+9.15%)

HITI High Tide
$6.68 /

+0.56 (+9.15%)

10/22/21 Desjardins
High Tide price target lowered to C$13.50 from C$15 at Desjardins
10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$6.68 /

+0.56 (+9.15%)

HITI High Tide
$6.68 /

+0.56 (+9.15%)

Hot Stocks
High Tide to acquire 80% of NuLeaf Naturals for $31.24M » 06:12
11/22/21
11/22
06:12
11/22/21
06:12
HITI

High Tide

$6.08 /

-0.12 (-1.94%)

High Tide announced that…

High Tide announced that it is entering into a definitive agreement pursuant to which High Tide will acquire 80% of NuLeaf Naturals for $31.24M, and will have a three-year option to acquire the remaining 20% of NuLeaf at any time. Founded in 2014 with its headquarters in Denver, Colorado, NuLeaf is a producer and distributor of cannabidiol, or CBD, wellness products. NuLeaf has a distribution reach in the natural products channel and recently secured an expansion with Sprouts Farmers Market from 33 retail locations to an additional 235 stores. Over the 12 months ended September 30, NuLeaf had over 5.1M site visits and an average order value of $120. Since its inception, NuLeaf has served approximately 330,000 unique customers through its e-commerce platform, and hundreds of thousands more through their other distribution channels. NuLeaf generated gross margins of 71% and adjusted EBITDA margins of 25% during the 12 months ended September 30, both of which are accretive to High Tide's consolidated margin profile. The transaction, which is an arm's length transaction, is subject to, among other things, receipt of required TSX Venture Exchange approval, and other customary conditions of closing, is expected to close in the coming weeks, implies an enterprise valuation of $39.05M, representing 7.1 projected 2021 adjusted EBITDA and recognition for $1.7M recently spent on upgrading NuLeaf's cGMP-certified facility. The consideration for the 80% acquired will be $31.24M in common shares of High Tide on the basis of a deemed price per High Tide Share equal to the volume weighted average price per High Tide Share on Nasdaq for the 10 consecutive trading days preceding closing of the transaction. Upon closing, NuLeaf Naturals will have approximately $500,000 of cash and inventory of approximately $500,000. In addition to the foregoing, NuLeaf's owners have agreed to grant High Tide an option to acquire all the remaining interests in NuLeaf not held by High Tide, and become the sole owner of NuLeaf, at an enterprise value equal to the trailing twelve months of adjusted EBITDA multiplied by 7.1. The call option will be exercisable at any time for a period of three years following the closing. In addition, High Tide has agreed to grant NuLeaf's owners an option to put to High Tide the remaining interests in NuLeaf not held by High Tide, at the same enterprise value of the call option. The put option will be exercisable by NuLeaf's owners for a period of 18 months following the 18 month anniversary of the closing. The consideration under the call option or the put option, if exercised, will be satisfied in cash. The High Tide Shares issued pursuant to the consideration are subject to a statutory hold period of four months and one day.

ShowHide Related Items >><<
HITI High Tide
$6.08 /

-0.12 (-1.94%)

HITI High Tide
$6.08 /

-0.12 (-1.94%)

10/22/21 Desjardins
High Tide price target lowered to C$13.50 from C$15 at Desjardins
10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$6.08 /

-0.12 (-1.94%)

HITI High Tide
$6.08 /

-0.12 (-1.94%)

Hot Stocks
High Tide to acquire 80% of NuLeaf Naturals for $31.24M » 06:05
11/22/21
11/22
06:05
11/22/21
06:05
HITI

High Tide

$6.08 /

-0.12 (-1.94%)

High Tide is pleased to…

High Tide is pleased to announce that it is taking another step towards solidifying itself as a major player within the global marketplace for hemp-derived CBD products, by entering into a definitive agreement pursuant to which High Tide will acquire 80% of NuLeaf Naturals for $31.24M, and will have a three-year option to acquire the remaining 20% of NuLeaf at any time. The Transaction, which is an arm's length transaction, is subject to, among other things, receipt of required TSX Venture Exchange approval, and other customary conditions of closing, is expected to close in the coming weeks, implies an enterprise valuation of $39.05M, representing 7.1 projected 2021 Adjusted EBITDA and recognition for $1.7M recently spent on upgrading NuLeaf's cGMP-certified facility. The consideration for the 80% acquired will be $31.24M in common shares of High Tide on the basis of a deemed price per High Tide Share equal to the volume weighted average price per High Tide Share on Nasdaq for the 10 consecutive trading days preceding closing of the Transaction. Upon closing, NuLeaf Naturals will have approximately $500,000 of cash and inventory of approximately $500,000.

ShowHide Related Items >><<
HITI High Tide
$6.08 /

-0.12 (-1.94%)

HITI High Tide
$6.08 /

-0.12 (-1.94%)

10/22/21 Desjardins
High Tide price target lowered to C$13.50 from C$15 at Desjardins
10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$6.08 /

-0.12 (-1.94%)

HITI High Tide
$6.08 /

-0.12 (-1.94%)

Over a month ago
Conference/Events
High Tide management to meet virtually with Roth Capital » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
HITI

High Tide

$5.32 /

-0.12 (-2.21%)

Virtual Meetings to be…

Virtual Meetings to be held on October 26-27 hosted by Roth Capital.

ShowHide Related Items >><<
HITI High Tide
$5.32 /

-0.12 (-2.21%)

HITI High Tide
$5.32 /

-0.12 (-2.21%)

10/22/21 Desjardins
High Tide price target lowered to C$13.50 from C$15 at Desjardins
10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$5.32 /

-0.12 (-2.21%)

HITI High Tide
$5.32 /

-0.12 (-2.21%)

Conference/Events
High Tide management to meet virtually with Roth Capital » 04:55
10/26/21
10/26
04:55
10/26/21
04:55
HITI

High Tide

$5.44 /

-0.13 (-2.33%)

Virtual Meetings to be…

Virtual Meetings to be held on October 26-27 hosted by Roth Capital.

ShowHide Related Items >><<
HITI High Tide
$5.44 /

-0.13 (-2.33%)

HITI High Tide
$5.44 /

-0.13 (-2.33%)

10/22/21 Desjardins
High Tide price target lowered to C$13.50 from C$15 at Desjardins
10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$5.44 /

-0.13 (-2.33%)

HITI High Tide
$5.44 /

-0.13 (-2.33%)

Recommendations
High Tide price target lowered to C$13.50 from C$15 at Desjardins » 09:37
10/22/21
10/22
09:37
10/22/21
09:37
HITI

High Tide

$5.76 /

-0.24 (-4.00%)

Desjardins analyst John…

Desjardins analyst John Chu lowered the firm's price target on High Tide to C$13.50 from C$15 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
HITI High Tide
$5.76 /

-0.24 (-4.00%)

HITI High Tide
$5.76 /

-0.24 (-4.00%)

10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$5.76 /

-0.24 (-4.00%)

HITI High Tide
$5.76 /

-0.24 (-4.00%)

Conference/Events
High Tide management to meet virtually with Roth Capital » 14:02
10/20/21
10/20
14:02
10/20/21
14:02
HITI

High Tide

$5.90 /

-0.09 (-1.50%)

Virtual Meetings to be…

Virtual Meetings to be held on October 26-27 hosted by Roth Capital.

ShowHide Related Items >><<
HITI High Tide
$5.90 /

-0.09 (-1.50%)

HITI High Tide
$5.90 /

-0.09 (-1.50%)

10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$5.90 /

-0.09 (-1.50%)

HITI High Tide
$5.90 /

-0.09 (-1.50%)

Hot Stocks
High Tide to transition cannabis retail stores to cannabis discount club concept » 06:12
10/20/21
10/20
06:12
10/20/21
06:12
HITI

High Tide

$5.99 /

+0.215 (+3.72%)

High Tide announced that…

High Tide announced that it is transitioning all of its cannabis retail stores to an innovative cannabis discount club concept, with exclusive benefits and everyday low prices for members of its Cabana Club loyalty plan. Modelled after a proven and leading membership-based grocery discount club retailer, High Tide will leverage its existing in-house brands and product lines to provide an exclusive customer experience for its 245,000+ Cabana Club members, which will drive customer loyalty and meaningfully expand the company's market share. Starting immediately, all of High Tide's retail cannabis stores will begin to offer steep club discounts on cannabis products in addition to existing member-only discounts on consumption accessories, as well as other exclusive benefits for members of the Cabana Club, which will remain free to join over the short-term. Members will also be given the exclusive ability to purchase items from High Tide's catalogue of proprietary consumption accessories, which will only be available in Canada through High Tide's retail brands, with wholesale sales of proprietary consumption accessories being discontinued in Canada in order to focus on providing value and exclusive high-quality products to Cabana Club members. Based on two successful pilot projects that were conducted beginning in mid-April, 2021, which yielded a 184% increase in consumption accessories sales, a 76%-100% increase on THC product sales, and a 272% increase in new signups for the Cabana Club, the company expects cannabis and consumption accessories sales volumes to continue to rise. This increase in sales will also accelerate High Tide's white-label product strategy to offer unique products to Cabana Club members. The company plans to initially roll out this retail concept across Canadian provinces where it currently operates retail cannabis stores, as well as in British Columbia, where it anticipates launching its first store in the near future. A driving focus of this rollout will be to convert consumers who currently buy products from the illicit market, a potential customer base worth at least $3B in annual sales. Over the longer-term, depending on the timelines of legalization and regulatory change in jurisdictions outside of Canada, High Tide's vision is to make the Cabana Club into a global cannabis community.

ShowHide Related Items >><<
HITI High Tide
$5.99 /

+0.215 (+3.72%)

HITI High Tide
$5.99 /

+0.215 (+3.72%)

10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$5.99 /

+0.215 (+3.72%)

HITI High Tide
$5.99 /

+0.215 (+3.72%)

On The Fly
Rising High: GrowGeneration terminates HGS Hydro acquisition » 09:50
10/14/21
10/14
09:50
10/14/21
09:50
GRWG

GrowGeneration

$21.10 /

+0.18 (+0.86%)

, CGC

Canopy Growth

$13.58 /

+0.29 (+2.18%)

, STMH

Stem Holdings

/

+

, HITI

High Tide

$5.75 /

+0.05 (+0.88%)

, FLGC

Flora Growth

$5.17 /

+0.04 (+0.78%)

, ACB

Aurora Cannabis

$7.22 /

+0.1 (+1.40%)

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CRON

Cronos Group

$5.52 /

+0.08 (+1.47%)

, CANN

General Cannabis

/

+

, GDNSF

Goodness Growth

$1.60 /

+ (+0.00%)

, GTBIF

Green Thumb Industries

$25.15 /

-0.0157 (-0.06%)

, IGC

India Globalization Capital

$1.43 /

+ (+0.00%)

, TLRY

Tilray

$10.46 /

+0.17 (+1.65%)

, TCNNF

Trulieve Cannabis

$27.42 /

-0.6 (-2.14%)

, ZYNE

Zynerba

$4.13 /

+ (+0.00%)

, ATAI

Atai Life Sciences

$12.78 /

-0.01 (-0.08%)

, CMPS

Compass Pathways

$31.70 /

+0.13 (+0.41%)

, RLMD

Relmada Therapeutics

$24.98 /

+ (+0.00%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
$4.13 /

+ (+0.00%)

TLRY Tilray
$10.46 /

+0.17 (+1.65%)

TCNNF Trulieve Cannabis
$27.42 /

-0.6 (-2.14%)

STMH Stem Holdings
/

+

RLMD Relmada Therapeutics
$24.98 /

+ (+0.00%)

IGC India Globalization Capital
$1.43 /

+ (+0.00%)

HITI High Tide
$5.75 /

+0.05 (+0.88%)

GTBIF Green Thumb Industries
$25.15 /

-0.0157 (-0.06%)

GRWG GrowGeneration
$21.10 /

+0.18 (+0.86%)

GDNSF Goodness Growth
$1.60 /

+ (+0.00%)

FLGC Flora Growth
$5.17 /

+0.04 (+0.78%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CRON Cronos Group
$5.52 /

+0.08 (+1.47%)

CMPS Compass Pathways
$31.70 /

+0.13 (+0.41%)

CGC Canopy Growth
$13.58 /

+0.29 (+2.18%)

CANN General Cannabis
/

+

ATAI Atai Life Sciences
$12.78 /

-0.01 (-0.08%)

ACB Aurora Cannabis
$7.22 /

+0.1 (+1.40%)

GRWG GrowGeneration
$21.10 /

+0.18 (+0.86%)

10/15/21 Craig-Hallum
GrowGeneration price target lowered to $35 from $55 at Craig-Hallum
10/14/21 Roth Capital
GrowGeneration price target lowered to $40 from $55 at Roth Capital
10/13/21 Lake Street
GrowGeneration price target lowered to $50 from $63 at Lake Street
10/13/21 Alliance Global Partners
GrowGeneration price target lowered to $45 from $55 at Alliance Global Partners
CGC Canopy Growth
$13.58 /

+0.29 (+2.18%)

10/15/21 Raymond James
INDIVA downgraded to Outperform from Strong Buy at Raymond James
10/14/21 Alliance Global Partners
Canopy Growth price target lowered to C$20 from C$25 at Alliance Global Partners
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 BofA
Canopy Growth downgraded to Neutral at BofA on near-term sales risk
STMH Stem Holdings
/

+

04/26/21 Noble Capital
Stem Holdings initiated with an Outperform at Noble Capital
HITI High Tide
$5.75 /

+0.05 (+0.88%)

10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
FLGC Flora Growth
$5.17 /

+0.04 (+0.78%)

10/13/21 Roth Capital
Flora Growth initiated with a Buy at Roth Capital
08/20/21 MKM Partners
Flora Growth price target raised to $11.50 from $6.00 at MKM Partners
06/23/21 MKM Partners
MKM Partners starts Flora Growth with Buy given its discount potential
06/22/21 MKM Partners
Flora Growth initiated with a Buy at MKM Partners
ACB Aurora Cannabis
$7.22 /

+0.1 (+1.40%)

09/29/21 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$7 at CIBC
09/28/21 MKM Partners
Aurora Cannabis upgraded to Neutral from Sell at MKM Partners
09/28/21 Canaccord
Aurora Cannabis price target lowered to C$6.50 from C$7.00 at Canaccord
09/28/21 Cowen
Aurora Cannabis miss came from medical not cannabis, says Cowen
CVSI CV Sciences
/

+

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/19/21 Piper Sandler
CV Sciences downgraded to Neutral on 'modest' growth at Piper Sandler
03/18/21 Piper Sandler
CV Sciences downgraded to Neutral from Overweight at Piper Sandler
CTST CannTrust
/

+

CRON Cronos Group
$5.52 /

+0.08 (+1.47%)

08/09/21 Canaccord
Cronos Group price target lowered to C$7 from C$7.50 at Canaccord
04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/28/21 BofA
BofA reinstates Cronos Group at Underperform with $7.50 price target
CANN General Cannabis
/

+

02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
GDNSF Goodness Growth
$1.60 /

+ (+0.00%)

GTBIF Green Thumb Industries
$25.15 /

-0.0157 (-0.06%)

08/12/21 BTIG
Green Thumb Industries price target raised to C$77 from C$73 at BTIG
08/05/21 Canaccord
Green Thumb Industries upgraded to Buy from Speculative Buy at Canaccord
07/07/21 Jefferies
Green Thumb Industries initiated with a Buy at Jefferies
05/13/21 Canaccord
Green Thumb Industries price target raised to C$54 from C$52 at Canaccord
IGC India Globalization Capital
$1.43 /

+ (+0.00%)

TLRY Tilray
$10.46 /

+0.17 (+1.65%)

10/08/21 Canaccord
Tilray price target lowered to $12 from $17 at Canaccord
10/08/21 Stifel
Tilray price target lowered to $10 from $11.50 at Stifel
09/16/21 Roth Capital
Tilray price target lowered to $12 from $25 at Roth Capital
09/10/21 Piper Sandler
Tilray price target lowered to $14 from $15 at Piper Sandler
TCNNF Trulieve Cannabis
$27.42 /

-0.6 (-2.14%)

10/04/21 Roth Capital
Trulieve Cannabis price target lowered to $65 from $72 at Roth Capital
10/04/21 Craig-Hallum
Trulieve Cannabis price target lowered to $70 from $80 at Craig-Hallum
08/05/21 Canaccord
Trulieve Cannabis upgraded to Buy from Speculative Buy at Canaccord
07/07/21 Jefferies
Trulieve Cannabis initiated with a Buy at Jefferies
ZYNE Zynerba
$4.13 /

+ (+0.00%)

05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
ATAI Atai Life Sciences
$12.78 /

-0.01 (-0.08%)

09/01/21 Jefferies
Jefferies starts Atai Life Sciences at Buy on 'deep pipeline' of psychedelics
09/01/21 Jefferies
Atai Life Sciences initiated with a Buy at Jefferies
07/14/21 Baader Helvea
Atai Life Sciences initiated with a Buy at Baader Helvea
07/13/21 Cowen
Atai Life Sciences initiated with an Outperform at Cowen
CMPS Compass Pathways
$31.70 /

+0.13 (+0.41%)

09/21/21 Citi
Citi opens 'positive Catalyst Watch' on Compass Pathways into depression data
07/13/21
Fly Intel: Top five analyst initiations
07/13/21 Citi
Compass Pathways initiated with a Buy at Citi
07/01/21 H.C. Wainwright
Compass Pathways price target raised to $100 from $65 at H.C. Wainwright
RLMD Relmada Therapeutics
$24.98 /

+ (+0.00%)

09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
07/28/21 Truist
Relmada Therapeutics price target raised to $90 from $75 at Truist
07/27/21 Goldman Sachs
Relmada Therapeutics' positive data removes overhang, says Goldman Sachs
07/27/21 SVB Leerink
Relmada Therapeutics shares could move into $35-$40 range, says SVB Leerink
ZYNE Zynerba
$4.13 /

+ (+0.00%)

TLRY Tilray
$10.46 /

+0.17 (+1.65%)

RLMD Relmada Therapeutics
$24.98 /

+ (+0.00%)

GTBIF Green Thumb Industries
$25.15 /

-0.0157 (-0.06%)

GRWG GrowGeneration
$21.10 /

+0.18 (+0.86%)

FLGC Flora Growth
$5.17 /

+0.04 (+0.78%)

CRON Cronos Group
$5.52 /

+0.08 (+1.47%)

CMPS Compass Pathways
$31.70 /

+0.13 (+0.41%)

CGC Canopy Growth
$13.58 /

+0.29 (+2.18%)

ATAI Atai Life Sciences
$12.78 /

-0.01 (-0.08%)

ACB Aurora Cannabis
$7.22 /

+0.1 (+1.40%)

  • 18
    Jun
  • 11
    May
  • 30
    Apr
  • 22
    Jan
  • 09
    Dec
  • 11
    Nov
FLGC Flora Growth
$5.17 /

+0.04 (+0.78%)

CMPS Compass Pathways
$31.70 /

+0.13 (+0.41%)

CGC Canopy Growth
$13.58 /

+0.29 (+2.18%)

TLRY Tilray
$10.46 /

+0.17 (+1.65%)

GRWG GrowGeneration
$21.10 /

+0.18 (+0.86%)

FLGC Flora Growth
$5.17 /

+0.04 (+0.78%)

CVSI CV Sciences
/

+

CGC Canopy Growth
$13.58 /

+0.29 (+2.18%)

ATAI Atai Life Sciences
$12.78 /

-0.01 (-0.08%)

ACB Aurora Cannabis
$7.22 /

+0.1 (+1.40%)

TLRY Tilray
$10.46 /

+0.17 (+1.65%)

IGC India Globalization Capital
$1.43 /

+ (+0.00%)

HITI High Tide
$5.75 /

+0.05 (+0.88%)

GRWG GrowGeneration
$21.10 /

+0.18 (+0.86%)

CRON Cronos Group
$5.52 /

+0.08 (+1.47%)

CGC Canopy Growth
$13.58 /

+0.29 (+2.18%)

ATAI Atai Life Sciences
$12.78 /

-0.01 (-0.08%)

ACB Aurora Cannabis
$7.22 /

+0.1 (+1.40%)

Conference/Events
High Tide management to meet virtually with Roth Capital » 04:55
10/14/21
10/14
04:55
10/14/21
04:55
HITI

High Tide

$5.71 /

-0.03 (-0.52%)

Virtual Meetings to be…

Virtual Meetings to be held on October 12-14 hosted by Roth Capital.

ShowHide Related Items >><<
HITI High Tide
$5.71 /

-0.03 (-0.52%)

HITI High Tide
$5.71 /

-0.03 (-0.52%)

10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$5.71 /

-0.03 (-0.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.